Keytruda 100 MG/4 ML vial 4ML
Ended Awarded
- Contract number
- SPE2DB25FL1X6
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $164,083
Award facts
- Contract value 100% obligated
- $164,083.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $164,083.00 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Keytruda 100 mg/4 ml vials. This firm fixed-price delivery order, awarded on September 5, 2025, is scheduled for completion by September 26, 2025, with performance taking place at the vendor's Park Ridge facility. The award carries no set-aside designation, allowing DMS Pharmaceutical Group to compete directly in the federal procurement marketplace based on its qualifications and pricing.
This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract (IDC) with the DLA valued at $499,999,999 and valid through November 2026. The parent IDC, established under the SPE2DB program, enables the agency to procure a comprehensive range of pharmaceutical products to support military health facility supply needs nationwide and globally. The Keytruda delivery represents a specialized oncology pharmaceutical product, consistent with the vendor's established portfolio of supplying prescription medications, biologics, and medical consumables to Department of Defense healthcare facilities, positioning DMS Pharmaceutical Group as a significant player in the federal pharmaceutical supply chain.
Quick answers
Who was awarded contract SPE2DB25FL1X6?
SPE2DB25FL1X6 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on September 5, 2025.
How much is contract SPE2DB25FL1X6 worth?
The government has obligated $164,083 on SPE2DB25FL1X6.
Is contract SPE2DB25FL1X6 an order under another contract?
Yes. SPE2DB25FL1X6 is a delivery order under SPE2DB20D9331, an indefinite delivery contract.
Was contract SPE2DB25FL1X6 competed?
The extent of competition for SPE2DB25FL1X6 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award